“Patient Protection and Affordable Care Act will limit physicians’ clinical decision-making authority in several important ways” according to speakers at Advamed conference
ADVAMED 2011: THE MEDTECH CONFERENCE DAY-TWO FOCUSES ON POLICIES TO PROMOTE LIFE CHANGING INNOVATION AROUND THE WORLD – PRESIDENT GEORGE W. BUSH TO SPEAK
Medtech Investing Europe is the premier and longest running Medtech investment partnering event in Europe. It’s 13th annual meeting takes place on October 4/5 at the King’s Fund, London
BIOTRONIK has announced the completion of enrollment in the BIOLUX P-I – a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.
Alan W. Portela to discuss entrance of consumer devices
into medical device ecosystem at top medtech event
An Interview with AdvaMed Conference Producer Ray Briscuso in advance of the event (Sept 26-28)
A surgeon at new York’s Montefiore Medical Center is receiving press coverage for his “breakthrough” spinal procedure to correct adolescent idiopathic scoliosis
Eucomed’s Chief Executive John Wilkinson’s message resonates with MedLatest in advance of Eucomed forum.
The European Society for Vascular Surgery(ESVS) celebrates its 25th anniversary at its annual congress in Athens from Sept 22-25.
Angiographically determined aneurysm recurrence was less common with hydrogel-coated than with bare-platinum coils, but clinical relevance remains unclear.
Biotronik PREVENT study indicates lower percent of right ventricular pacing (%VP) correlates with less risk of heart failure (HF) hospitalization, mortality and atrial fibrillation (AF)
Covidien has announced the start of patient enrollment in the ev3 DEFINITIVE(TM) Anti-Restenosis study taking place at Imelda Hospital in Belgium with Dr. Patrick Peeters.
The results of the first randomised controlled trial comparing percutaneous mitral valve repair against conventional mitral valve surgery suggests the short term advantages of the technique may be outweighed by inferior long term results compared with conventional surgery.
Covidien has announced the completion of enrollment of 600 patients in its post-marketing study comparing outcomes of inguinal hernia repair with self-fixating mesh to gold-standard repair technique using sutures